179
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Association Between Serum Uric Acid and Lung Function in People with and without Chronic Obstructive Pulmonary Disease

, , , ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 1069-1080 | Published online: 05 May 2022

References

  • van der Vliet A, Neill O, Cross CE, et al. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol. 1999;276(2):L289–L296. doi:10.1152/ajplung.1999.276.2.L289
  • Kelly FJ, Blomberg A, Frew A, et al. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am J Respir Crit Care Med. 1996;154:1700–1705. doi:10.1164/ajrccm.154.6.8970358
  • Peden DB, Hohman R, Brown ME, et al. Uric acid is a major antioxidant in human nasal airway secretions. Proc Natl Acad Sci U S A. 1990;87:7638–7642. doi:10.1073/pnas.87.19.7638
  • So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120(6):1791–1799. doi:10.1172/JCI42344
  • Lyngdoh T, Marques-Vidal P, Paccaud F, et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 2011;6(5):e19901. doi:10.1371/journal.pone.0019901
  • Song JU, Hwang J, Ahn JK. Serum uric acid is positively associated with pulmonary function in Korean health screening examinees. Mod Rheumatol. 2017;27:1057–1065. doi:10.1080/14397595.2017.1285981
  • Nicks NE, O’Brien MM, Bowler RP. Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers. COPD. 2011;8:264–269. doi:10.3109/15412555.2011.579202
  • Kobylecki CJ, Vedel-Krogh S, Afzal S, et al. Nordestgaard, Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population. Thorax. 2018;73(8):748–757. doi:10.1136/thoraxjnl-2017-210273
  • Fujikawa H, Sakamoto Y, Masuda N, et al. Higher blood uric acid in female humans and mice as a protective factor against pathophysiological decline of lung function. Antioxidants. 2020;9(5):387. doi:10.3390/antiox9050387
  • Elsayed NE, Nakashima JM, Postlethwait EM. Measurement of uric acid as a marker of oxygen tension in the lung. Arch Biochem Biophys. 1993;302(1):228–232. doi:10.1006/abbi.1993.1204
  • Kahnert K, Alter P, Welte T, et al. Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. Respir Res. 2018;19(1):110. doi:10.1186/s12931-018-0815-y
  • Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung. 2007;185(1):21–24. doi:10.1007/s00408-006-0076-2
  • Jeong H, Baek SY, Kim SW, et al. Gender-specific association of serum uric acid and pulmonary function: data from the Korea National Health and Nutrition Examination Survey. Medicine. 2021;57:953.
  • Garcia-Larsen V, Chinn S, Rodrigo R, et al. Relationship between oxidative stress-related biomarkers and antioxidant status with asthma and atopy in young adults: a population-based study. Clin Exp Allergy. 2009;39(3):379–386. doi:10.1111/j.1365-2222.2008.03163.x
  • Horsfall LJ, Nazareth I, Petersen I. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014;69(11):1021–1026. doi:10.1136/thoraxjnl-2014-205271
  • Domagk GF, Schlicke HH. A colorimetric method using uricase and peroxidase for the determination of uric acid. Anal Biochem. 1968;22(2):219–224. doi:10.1016/0003-2697(68)90309-6
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Zhou Y, Hu G, Wang D, et al. Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. BMJ. 2010;341(2):c6387. doi:10.1136/bmj.c6387
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
  • Enright PL, Studnicka M, Zielinski J. Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting. Eur Respir Mon. 2005;31:1–14.
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP
  • Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;16:5–40.
  • Zheng J, Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J. 2002;115(1):5054.
  • Aida Y, Shibata Y, Osaka D, et al. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. Int J Med Sci. 2011;8(6):470–478. doi:10.7150/ijms.8.470
  • Bartziokas K, Papaioannou AI, Loukides S, et al. serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J. 2014;43(1):43–53. doi:10.1183/09031936.00209212
  • Shaheen SO. Uric acid, lung function and COPD: a causal link is unlikely. Thorax. 2018;73(8):697–698. doi:10.1136/thoraxjnl-2017-211230
  • De Vera MA, Rahman MM, Bhole V, et al. The independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis. 2010;69:1162–1164. doi:10.1136/ard.2009.122770
  • McNeil JD, Wiebkin OW, Betts WH, et al. Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis. 1985;44:780–789. doi:10.1136/ard.44.11.780
  • Uchiyama H, Dobashi Y, Ohkouchi K, et al. Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J Biol Chem. 1990;265:7753–7759. doi:10.1016/S0021-9258(19)38993-8
  • McKee CM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996;98:2403. doi:10.1172/JCI119054
  • Ozanturk E, Ucar ZZ, Varol Y, et al. Urinary uric acid excretion as an indicator of severe hypoxia and mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Rev Port Pneumol. 2016;22:18–26. doi:10.1016/j.rppnen.2015.06.002
  • Braghiroli A, Sacco C, Erbetta M, et al. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis. 1993;148:173–178. doi:10.1164/ajrccm/148.1.173
  • Saito H, Nishimura M, Shibuya E, et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest. 2002;122(5):1686–1694. doi:10.1378/chest.122.5.1686
  • Sundh J, Ekström M. Risk factors for developing hypoxic respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2095–2100. doi:10.2147/COPD.S140299
  • Wells JM, Estepar RS, McDonald MN, et al. Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med. 2016;16:169. doi:10.1186/s12890-016-0331-0
  • Higashimoto Y, Honda N, Yamagata T, et al. Exertional dyspnoea and cortical oxygenation in patients with COPD. Eur Respir J. 2015;46(6):1615–1624.
  • Li H, Chen Y. Serum uric acid level as a biomarker for chronic obstructive pulmonary disease: a meta-analysis. J Int Med Res. 2021;49(1):300060520983705. doi:10.1177/0300060520983705
  • Zhang X, Liu L, Liang R, Jin S. Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:2519–2523. doi:10.2147/COPD.S87202
  • Fukuhara A, Saito J, Sato S, et al. The association between risk of airflow limitation and serum uric acid measured at medical health check-ups. Int J Chron Obstruct Pulmon Dis. 2017;12:1213–1219. doi:10.2147/COPD.S126249